UNIVERSITEIT MAASTRICHT

Their core work

Maastricht University is a research-intensive Dutch university with deep strengths in biomedical sciences, neuroscience, and health innovation. Their H2020 portfolio reveals a university that bridges fundamental life science research — brain mapping, regenerative medicine, immunotherapy — with applied technology development in bioprinting, organ-on-chip systems, and AI-driven diagnostics. They are particularly strong in translating biomedical discoveries into clinical and industrial applications, including additive manufacturing for tissue engineering. Beyond health, they maintain active research lines in migration studies, innovation policy, and food science.

What they specialise in

How they've shifted over time

In the early H2020 period (2015–2018), Maastricht focused heavily on brain mapping and neuroinformatics (human brain simulation, HPC, reconstruction), migration and transnationalism studies, and fundamental biomarker and immunotherapy research. By 2019–2022, the portfolio shifted decisively toward applied biomedical engineering — bioprinting, organoids, organ-on-chip — and AI/deep learning applications in health. Open science and interdisciplinary co-creation also emerged as distinct recent themes, suggesting the university is positioning itself at the intersection of computational methods and life sciences.

Maastricht is converging its neuroscience and biomedical strengths with AI and advanced manufacturing, making them a strong future partner for projects combining computational biology with tissue engineering or personalized medicine.

How they like to work

With 85 projects as coordinator (35% of portfolio) and 154 as participant, Maastricht is a confident project leader that also collaborates broadly. Their network of 1,773 unique partners across 69 countries indicates a hub organization — they rarely repeat partners and instead build fresh consortia tailored to each project. This makes them an accessible partner: they are experienced at onboarding new collaborators and managing large, diverse teams.

Maastricht has worked with 1,773 distinct consortium partners across 69 countries, making it one of the most broadly connected universities in H2020. While rooted in European partnerships, its reach extends well beyond EU borders, reflecting its international orientation and the Maastricht region's cross-border position (NL/BE/DE).

What sets them apart

Maastricht occupies a rare position combining world-class neuroscience with advanced biofabrication (bioprinting, organ-on-chip, additive manufacturing for tissue scaffolds) — a combination few European universities can match at this scale. Their 35% coordinator rate demonstrates institutional capacity to lead complex projects, not just contribute expertise. Located at the crossroads of the Netherlands, Belgium, and Germany, they bring a genuinely cross-border European perspective and an unusually large, non-repetitive partner network.

Highlights from their portfolio

• CELL HYBRIDGE
  €1.5M ERC-level grant as coordinator, pioneering 3D-printed scaffolds for stem cell delivery in regenerative medicine — a flagship of their bioprinting expertise.
• MULTICONNECT
  €1.5M coordinator grant for multimodal brain circuit imaging, representing their deep commitment to computational neuroscience at the highest funding tier.
• FAST
  €953K coordinator project on functionally graded additive manufacturing, demonstrating their ability to bridge manufacturing technology with biomedical applications.